Loading…
CIK 0002006045 • 2 13F filings • Feb 12, 2026 – May 12, 2026
Import this data to Google Sheets with:
=jivedata("symbiosis-capital-partners-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 2 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| Aardvark Therapeutics, Inc. | COM | $6.3M | 5.7% | 476,595 SH | New |
| Aldeyra Therapeutics Inc | COM NEW | $13.2M | 12.1% | 2,555,000 SH | New |
| Clene Nanomedicine Inc. | COM NEW | $4.5M | 4.1%Prev: 4.0% | 770,495 SH | Increased+339,401 SH |
| Evommune, Inc. | COM SHS | $21.9M | 20.0%Prev: 55.8% | 1,280,778 SH | Decreased |
| Generation Bio Co | COM NEW | $3.8M | 3.4% | 665,000 SH | New |
| Inventiva S.A. | ADS | $12.1M | 11.0%Prev: 24.8% | 2,600,000 SH | Decreased+246,000 SH |
| Nuvation Bio Inc | COM CL A | $11.2M | 10.2% | 1,250,000 SH | New |
| Precigen Inc | COM | $12.5M | 11.5% | 3,000,000 SH | New |
| Rani Therapeutics Holdings, Inc. | COM CL A | $8.5M | 7.8%Prev: 5.1% | 6,300,000 SH | Increased+2,632,415 SH |
| Surrozen, Inc. | *W EXP 08/01/203 | $3K | 0.0%Prev: 0.0% | 150,000 SH | Increased |
| Verastem Inc | COM NEW | $15.4M | 14.1% | 2,000,000 SH | New |